Source: International Congress 2019 – Evaluation of basic science in airway diseases
Disease area: Airway diseases



Rating:

Share or cite this content

Citations should be made in the following way:
C. Chang (Beijing, China), Y. Liang (Beijing, China), J. Wang (Beijing, China), Y. Sun (Beijing, China), W. Yao (Beijing, China). Metabolomic profiling differences among asthma, COPD and healthy controls: a LC-MS-based metabolomics analysis. 1701

Member's Comments

No comment yet.

Related content which might interest you: Altered serum metabolomics in COPD: analysis of the SPIROMICS cohort Source: International Congress 2018 – COPD phenotypes: a1 antitrypsin deficiency and beyond Year: 2018 Metabolomic fingerprinting in the identification of biomarkers in COPD patients Source: Annual Congress 2012 - Basic and translational studies in COPD Year: 2012 Plasma metabolomic signature in COPD patients: Associations to proteomic profile and clinical outcomes Source: Annual Congress 2013 –COPD mechanisms Year: 2013 High-throughput analysis of induced sputum from the U-BIOPRED study using novel proteomic and data mining approaches Source: Annual Congress 2013 –Origins and diagnosis of asthma Year: 2013 Gene signalling heterogeneity in exacerbations of COPD determined by microarray analysis of PBMC mRNA Source: International Congress 2015 – Respiratory translational research: novel mechanisms, diagnostic markers and Space Odyssey Year: 2015 A CADSET WP4 transcriptomic analysis of Asthma and COPD overlap Source: Virtual Congress 2020 – Asthma science: novel targets and mechanisms Year: 2020 GC MS based untargeted metabolomics for understanding the pathophysiology of asthma COPD overlap (ACO) Source: International Congress 2018 – Biomarkers of COPD and asthma-COPD overlap syndrome (ACOS) Year: 2018 Microarray profiling of COPD patients versus non-COPD smokers reveals possible disease biomarkers Source: Annual Congress 2013 –Systemic and airway biomarkers in respiratory diseases Year: 2013 COPD phenotypes revealed by the integrated sputum microbiome and proteome analysis in COPDMAP cohort Source: International Congress 2019 – Host-microbe interactions in lung disease and exacerbations Year: 2019 Mass spectrometry proteomic biomarkers identify acute COPD exacerbations Source: Virtual Congress 2020 – Burden and predictive factors for chronic lung diseases and comorbidity Year: 2020 A NMR-based metabolomics approach to the assessment of inhaled pharmacotherapy in patients with COPD Source: International Congress 2019 – Basic research of airway diseases Year: 2019 Selection of protein expression signatures by interfacing pathophysiology and proteomics technology in smokers and never-smokers Source: Eur Respir J 2005; 26: Suppl. 49, 441s Year: 2005 A comparative proteomic profiling of the human erythrocyte membrane in COPD patients Source: Annual Congress 2009 - New results in molecular pathology and functional genomics of non-neoplastic lung diseases Year: 2009 Preliminary proteomics analysis for sepsis biomarkers with iTRAQ labeling and LC-MS/MS Source: Annual Congress 2013 –Research questions on how viruses affect the respiratory system Year: 2013 Metabolomic analysis of severe COPD. Study of biomarkers in the CHAIN cohort. Source: International Congress 2019 – New molecular signatures in COPD, lung cancer and a1-antitrypsin deficiency Year: 2019 Cluster analysis to identify phenotypes in COPD Source: Annual Congress 2009 - Quality of life and symptoms in COPD Year: 2009 Further resolution of non-T2 asthma subtypes from high-throughput sputum transciptomics data in U-BIOPRED Source: International Congress 2018 – Innovative therapies in asthma and COPD Year: 2018 Transcriptome profiling of platelets from patients with severe asthma. Source: Virtual Congress 2021 – New insights into the airway immunology of lung disease Year: 2021 Discrimination of sepsis metabolic profiles revealed by LC/MS-MS based metabonomics approach Source: Annual Congress 2013 –Infection, sepsis and outcomes in ICU Year: 2013